COPD is more than just lung function: Let’s not forget depression

García-Sanz, María-Teresa; González-Barcala, Francisco-Javier.
Arch. bronconeumol. (Ed. impr.) ; 57(8): 519-520, Ag. 2021.
Artículo en Inglés | IBECS (España) | ID: ibc-211749

Documentos relacionados

  1. The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes.
  2. Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans.
  3. Depression: why drugs and electricity are not the answer.
  4. Transitions in depression: if, how, and when depressive symptoms return during and after discontinuing antidepressants.
  5. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
  6. Depression and suicidality in COPD: understandable reaction or independent disorders?
  7. Recent Advances in Analytical Techniques for Antidepressants Determination in Complex Biological Matrices: A Review.
  8. Brain-Hazardous Medications and Potential Subadequate Antidepressant Dosing in Older Surgical Patients Receiving Home Antidepressants: An Observational Study of a Large US Health System.
  9. Histological assessment of liver and stomach damage caused by pyridazinone derivative antidepressant agents.
  10. When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial).